Biopharma companies can help healthcare providers and specialist physicians stay abreast of scientific and medical information. Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function. Related Practice Life Sciences & Pharma
Healthcare Services • Executive Insights Asia-Pacific 2021 Hospital Priorities: Settling Into the New Normal March 11, 2021 L.E.K. Consulting conducted the 2021 APAC Hospital Priority Survey with 411 hospital executives across both public and private hospitals in countries1…
Healthcare Services • Presentations Election 2020 Insights, Part 2 December 16, 2020 A divided government favors policies that have bipartisan support, or those that can be implemented via executive order.
Life Sciences & Pharma • Article Omnichannel Engagement in Pharma — Key Success Factors and Case Examples May 24, 2021 Pharma confidence in juggling traditional channels with digital means is certainly increasing.
Life Sciences & Pharma • Special Report Making the AI Leap: Boosting Singapore’s Competitiveness in Biotech December 17, 2020 Following years of investment through artificial intelligence (AI)-centric venture funds and government grants, Singapore has moved beyond applying AI to…
Life Sciences & Pharma • Executive Insights Approaching Japan’s Increasingly Challenging and Subjective Drug Pricing Environment November 17, 2020 Companies need to understand Japan’s pricing system and anticipate and plan for potential challenges both in advance of and subsequent to launch.
Life Sciences & Pharma • Video / Webinar Webinar Recording — Life Sciences: What To Expect in 2021 January 28, 2021 Join experts from L.E.K. Consulting as they present their insights into recent trends and expected changes to the life sciences sector this year.
